SLS BIO Co., Ltd (KOSDAQ:246250)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,969.00
+85.00 (4.51%)
At close: Jun 9, 2025

SLS BIO Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2015
Period Ending
Jun '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '15
26,88926,88926,28835,23333,970-
Market Cap Growth
-16.57%2.29%-25.39%3.72%--
Enterprise Value
20,82023,05818,91733,62836,114-
Last Close Price
1969.001969.001925.002554.402462.82-
PE Ratio
--78.3324.5712.02-
PS Ratio
6.756.753.143.913.16-
PB Ratio
3.523.522.102.625.07-
P/TBV Ratio
3.593.592.132.675.20-
P/FCF Ratio
--97.3916.3010.25-
P/OCF Ratio
--15.2310.268.42-
EV/Sales Ratio
5.235.792.263.733.36-
EV/EBITDA Ratio
--11.6514.569.69-
EV/EBIT Ratio
--65.7732.6214.90-
EV/FCF Ratio
-5.61-70.0815.5610.90-
Debt / Equity Ratio
0.170.170.140.160.380.83
Debt / EBITDA Ratio
--1.050.910.683.61
Debt / FCF Ratio
--6.340.970.7642.09
Net Debt / Equity Ratio
-0.26-0.26-0.48-0.540.000.43
Net Debt / EBITDA Ratio
0.710.71-3.68-3.14-0.011.88
Net Debt / FCF Ratio
0.540.54-22.12-3.35-0.0121.96
Asset Turnover
0.290.290.490.61-0.66
Inventory Turnover
34.2934.2928.1120.82--
Quick Ratio
2.532.536.456.572.731.24
Current Ratio
2.852.856.646.772.971.26
Return on Equity (ROE)
-48.68%-48.68%2.58%14.22%-6.63%
Return on Assets (ROA)
-18.60%-18.60%1.05%4.35%-3.45%
Return on Invested Capital (ROIC)
-74.37%-67.48%4.27%16.00%35.13%7.77%
Return on Capital Employed (ROCE)
-42.60%-42.60%1.90%6.40%25.00%7.50%
Earnings Yield
-18.24%-18.24%1.28%4.07%8.32%-
FCF Yield
-13.79%-13.79%1.03%6.13%9.76%-
Payout Ratio
--114.33%---
Buyback Yield / Dilution
1.40%1.40%-116.87%-2.55%-37.54%-14.68%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.